Claudia Scheckel
Can you tell us more about Oncobit and the reasons you decided to found it? Two of my co-founders are professors at the University and University Hospital of Zurich and experienced first-hand the limitations linked to cancer monitoring. So Oncobit was really founded out of an unmet need. What are some of the key challenges you faced when transitioning from academia to entrepreneurship and the MedTech industry, and how did you overcome them? To be honest I believe academia has prepared me quite well for my entrepreneurial journey at Oncobit in a lot of ways.